/GBLX
GBLX Stock - GB Sciences, Inc.
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
46
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.46
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GBLX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta9.86
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $3.12M |
| Gross Profit | $-624 | $-61,660 | $-70,488 | $-47,353 | $-126,000 |
| Gross Margin | N/A | N/A | N/A | N/A | -4.0% |
| Operating Income | $-1,421,000 | $-1,672,000 | $-1,869,000 | $-2,002,000 | $-12,010,000 |
| Net Income | $-1,362,000 | $-4,125,000 | $-531,000 | $-3,725,000 | $-12,374,000 |
| Net Margin | N/A | N/A | N/A | N/A | -396.5% |
| EPS | $-0.00 | $-0.01 | $-0.00 | $-0.01 | $-0.04 |
Company Overview
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GBLXBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2025
EPS Surprise History
Q3 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q3 24
No data
Q3 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 28, 2025 | — | $-0.00 | — | — |
Q1 2025 | Mar 28, 2025 | — | — | — | — |
Q1 2025 | Feb 10, 2025 | — | $-0.00 | — | — |
Q3 2024 | Aug 30, 2024 | — | $-0.00 | — | — |
Q3 2024 | Jul 30, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 12, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 20, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.00 | — | — |
Q3 2023 | Jul 14, 2023 | — | $-0.01 | — | — |
Q1 2023 | Feb 3, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 9, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 11, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q1 2022 | Feb 11, 2022 | — | $0.01 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 13, 2021 | — | $-0.00 | — | — |
Q3 2021 | Jul 6, 2021 | — | $-0.00 | — | — |
Q1 2021 | Feb 16, 2021 | — | $-0.00 | — | — |
Q4 2020 | Nov 13, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 2, 2020 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GBLX
What is GBLX's current stock price?
GB Sciences, Inc. (GBLX) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for GBLX?
No analyst price targets are currently available for this stock.
What sector is GB Sciences, Inc. in?
GB Sciences, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is GBLX's market cap?
GB Sciences, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does GBLX pay dividends?
No, GB Sciences, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACUS
Acusphere, Inc.
$0.00
Mkt Cap: $0.0B
BIOAF
Bioasis Technologies Inc.
$0.00
Mkt Cap: $0.0B
EHOS
Ehouse Global, Inc.
$0.00
Mkt Cap: $0.0B
GSTC
GlobeStar Therapeutics Corporation
$0.00
Mkt Cap: $0.0B
HTDS
Hard to Treat Diseases Inc.
$0.00
Mkt Cap: $0.0B
IRBS
IR Biosciences Holdings Inc.
$0.00
Mkt Cap: $0.0B
MOBO
Mobile Lads Corp.
$0.00
Mkt Cap: $0.0B
PBLA
Panbela Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
RGMP
Regnum Corp.
$0.00
Mkt Cap: $0.0B
TSTS
That Marketing Solution, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to GBLX for comparison